ArticleInternational journal of oncology2020

SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.